Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Neuberg

Showing results (51-60 of 115) with videos related to

Pageof 12
Sort By:
Bone Marrow Transplantation|May 11, 2004
CD8+ cell depletion of donor lymphocyte infusions using cd8 monoclonal antibody-coated high-density microparticles (CD8-HDM) after allogeneic hematopoietic stem cell transplantation: a pilot studyE P Alyea, C Canning, D Neuberg, et al.
Leukemia|February 6, 2004
Decision-making and quality of life in older adults with acute myeloid leukemia or advanced myelodysplastic syndromeM A Sekeres, R M Stone, D Zahrieh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Constitutional WT1 mutations in Wilms' tumor patientsL Diller, M Ghahremani, J Morgan, et al.
International Journal of Radiation Oncology, Biology, Physics|March 17, 1999
Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagusB D Minsky, D Neuberg, D P Kelsen, et al.
American Journal of Hematology|April 3, 2001
Rare adult acute lymphocytic leukemia with CD56 expression in the ECOG experience shows unexpected phenotypic and genotypic heterogeneityE Paietta, D Neuberg, S Richards, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
A Phase II study of adjuvant therapy with anti-B4-blocked ricin after autologous bone marrow transplantation for patients with relapsed B-cell non-Hodgkin's lymphomaM L Grossbard, P S Multani, A S Freedman, et al.
Cytometry. Part B, Clinical Cytometry|April 27, 2004
A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypesE Paietta, O Goloubeva, D Neuberg, et al.
Blood|December 1, 1994
Inhibition of calcineurin phosphatase activity in adult bone marrow transplant patients treated with cyclosporine AS Y Pai, D A Fruman, T Leong, et al.
Bone Marrow Transplantation|March 29, 2000
Changes in T cell receptor repertoire associated with graft-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusionE Orsini, E P Alyea, R Schlossman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 23, 2011
Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysisJ A Barnes, A S Lacasce, Y Feng, et al.
Pageof 12

Showing results (51-60 of 115) with videos related to

Sort By:
Pageof 12
Bone Marrow Transplantation|May 11, 2004
CD8+ cell depletion of donor lymphocyte infusions using cd8 monoclonal antibody-coated high-density microparticles (CD8-HDM) after allogeneic hematopoietic stem cell transplantation: a pilot studyE P Alyea, C Canning, D Neuberg, et al.
Leukemia|February 6, 2004
Decision-making and quality of life in older adults with acute myeloid leukemia or advanced myelodysplastic syndromeM A Sekeres, R M Stone, D Zahrieh, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 1998
Constitutional WT1 mutations in Wilms' tumor patientsL Diller, M Ghahremani, J Morgan, et al.
International Journal of Radiation Oncology, Biology, Physics|March 17, 1999
Final report of Intergroup Trial 0122 (ECOG PE-289, RTOG 90-12): Phase II trial of neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagusB D Minsky, D Neuberg, D P Kelsen, et al.
American Journal of Hematology|April 3, 2001
Rare adult acute lymphocytic leukemia with CD56 expression in the ECOG experience shows unexpected phenotypic and genotypic heterogeneityE Paietta, D Neuberg, S Richards, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 1999
A Phase II study of adjuvant therapy with anti-B4-blocked ricin after autologous bone marrow transplantation for patients with relapsed B-cell non-Hodgkin's lymphomaM L Grossbard, P S Multani, A S Freedman, et al.
Cytometry. Part B, Clinical Cytometry|April 27, 2004
A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypesE Paietta, O Goloubeva, D Neuberg, et al.
Blood|December 1, 1994
Inhibition of calcineurin phosphatase activity in adult bone marrow transplant patients treated with cyclosporine AS Y Pai, D A Fruman, T Leong, et al.
Bone Marrow Transplantation|March 29, 2000
Changes in T cell receptor repertoire associated with graft-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple myeloma after donor lymphocyte infusionE Orsini, E P Alyea, R Schlossman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 23, 2011
Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt's lymphoma: a retrospective analysisJ A Barnes, A S Lacasce, Y Feng, et al.
Pageof 12